The HRs comparing tirzepatide to the control were 0.80 (95% CI, 0.57-1.11) for MACE-4, 0.90 (95% CI, 0.50-1.61) for cardiovascular death, and 0.80 (95% CI, 0.51-1.25) for all-cause death
They suspect that both cost and negative side effects cause people to stop using the drugs
Provides a radiant glow with consistent use
Whether youre moving from Invokana to Jardiance, Farxiga, or another med, its a good idea to work with your doctor to understand why you need a change
Fatigue can come from thyroid disease, but also from sleep disruption, low energy availability, stress, iron issues, inflammation, or other endocrine changes
Naltrexone (Apo-Naltrexone/ReVia